Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention

被引:266
|
作者
Valgimigli, Marco
Serruys, Patrick Washington [1 ]
Tsuchida, Keiichi
Vaina, Sophia
Morel, Marie-Angele
van den Brand, Marcel J.
Colombo, Antonio
Morice, Marie Claude
Dawkins, Keith
de Bruyne, Bernard
Kornowski, Ran
de Servi, Stefano
Guagliumi, Giulio
Jukema, J. Wouter
Mohr, Frederick W.
Kappetein, Arie-Pieter
Wittebols, Kristel
Stoll, Hans-Peter
Boersma, Eric
Parrinello, Giovanni
机构
[1] Erasmus MC, Thoraxctr, Rotterdam, Netherlands
[2] Cardialysis BV, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, NL-2300 RA Leiden, Netherlands
[4] Hosp San Raffaele, I-20132 Milan, Italy
[5] Osped Civile, Legnano, Italy
[6] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
[7] Univ Brescia, Med Stat Unit, I-25121 Brescia, Italy
[8] Inst Cardiovasc Paris Sud, Massy, France
[9] Southampton Univ Hosp, Wessex Cardiac Unit, Southampton, Hants, England
[10] Onze Lieve Vrouw Hosp, Aalst, Belgium
[11] Rabin Med Ctr, Petah Tiqwa, Israel
[12] Univ Leipzig, Heartctr, Dept Cardiac Surg, D-7010 Leipzig, Germany
[13] Johnson & Johnson Co, Cordis Corp, Miami Lakes, FL USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 99卷 / 08期
关键词
D O I
10.1016/j.amjcard.2006.11.062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Syntax score (SXscore) was recently developed as a comprehensive angiographic scoring system aiming to assist in patient selection and risk stratification of patients with extensive coronary artery disease undergoing contemporary revascularization. A validation of this angiographic classification scheme is lacking. We assessed its predictive value in patients who underwent percutaneous intervention (PCI.) for 3-vessel disease and explored its performance in comparison with the modified lesion classification system of the American Heart Association/American College of Cardiology. The SXscore, applied to 1,292 lesions in 306 patients who underwent PCI for 3-vessel disease in the Arterial Revascularization Therapies Study Part II, was 4 to 54.5, and after a median of 370 days (range 274 to 400) predicted the rate of major adverse cardiac and cerebrovascular events (hazard ratio 1.08/U increase, 95 % confidence interval 1.05 to 1.11, p < 0.0001), with patients in the highest SXscore tertile having a significantly higher event rate (27.9%) than patients in the lowest tertile (8.7%, hazard ratio 3.5, 95% confidence interval 1.7 to 7.4, p = 0.001). By multivariable analyses, SXscore independently predicted outcome with an almost fourfold adjusted increase in the risk of major adverse cardiac and cerebrovascular events in patients with high versus low values based on the discrimination level provided by classification and regression tree analysis. Compared with the modified lesion classification scheme of the American Heart Association/American College of Cardiology, SXscore showed a greater discrimination ability (c-index 0.58 +/- 0.08 vs 0.67 +/- 0.08, respectively, p < 0.001) and a better goodness of fit with the Hosmer-Lemeshow statistic. In conclusion, the SXscore is a promising tool to risk stratify outcome in patients with extensive coronary artery disease undergoing contemporary PCI. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1072 / 1081
页数:10
相关论文
共 50 条
  • [21] Modified residual SYNTAX score and clinical outcomes in patients with multivessel disease undergoing percutaneous coronary intervention
    Park, Taek Kyu
    Hahn, Joo-Yong
    Yang, Jeong Hoon
    Bin Song, Young
    Choi, Seung-Hyuk
    Choi, Jin-Ho
    Lee, Sang Hoon
    Ahn, Joonghyun
    Carriere, Keumhee Cho
    Gwon, Hyeon-Cheol
    EUROINTERVENTION, 2017, 13 (01) : 87 - 96
  • [22] Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
    Mohr, Friedrich W.
    Morice, Marie-Claude
    Kappetein, A. Pieter
    Feldman, Ted E.
    Stahle, Elisabeth
    Colombo, Antonio
    Mack, Michael J.
    Holmes, David R., Jr.
    Morel, Marie-angele
    Van Dyck, Nic
    Houle, Vicki M.
    Dawkins, Keith D.
    Serruys, Patrick W.
    LANCET, 2013, 381 (9867): : 629 - 638
  • [23] Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase
    Kappetein, AP
    Dawkins, KD
    Mohr, FW
    Morice, MC
    Mack, MJ
    Russell, ME
    Pomar, J
    Serruys, PWJC
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2006, 29 (04) : 486 - 490
  • [24] Very long-term prognostic value of clinical SYNTAX score in patients undergoing percutaneous coronary intervention for left main coronary artery disease
    Lee, J.
    Jung, M.
    Kwak, H.
    Chang, E.
    Jung, J.
    Rhee, E.
    Park, Y.
    Park, B.
    Kim, H.
    Kim, N.
    Jang, S.
    Bae, M.
    Yang, D.
    Park, H.
    Cho, Y.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [25] Outcome of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Patients With Intermediate SYNTAX II Score
    Etman, Waleed
    Lout, Mohamed
    Ahmed, Kamal
    Eltahan, Salah
    Rayan, Amr
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (02)
  • [26] High-risk percutaneous coronary intervention in three-vessel coronary artery disease and aortic stenosis with Impella support
    Bendetti, Alice
    D'Angelo, Livio
    Masiero, Giulia
    Fraccaro, Chiara
    Pavei, Andrea
    Napodano, Massimo
    Tarantini, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N52 - N52
  • [27] Concentrations of circulating adiponectin and adipocyte-fatty acid binding protein in patients with three-vessel coronary artery disease: a comparison with coronary lesion complexity as characterized by syntax score
    Coskun, Cihan
    Gumus, Alper
    Emre, Humeyra Ozturk
    Ozkan, Birol
    Pala, Selcuk
    Koldas, Macit
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2018, 43 (01): : 30 - 39
  • [28] TEN YEAR SURVIVAL OF THREE-VESSEL CORONARY DISEASE PATIENTS IN MIRROR OF RETROSPECTIVE SYNTAX SCORE CALCULATION
    Balogh, L.
    Bereczky, Z.
    Katona, E.
    Kolodzey, G.
    Mandzak, A.
    Czuriga, I.
    CARDIOLOGY, 2015, 132 : 212 - 212
  • [29] The 'SYNTAX Score derivatives' to predict clinical outcomes after percutaneous coronary intervention with Everolimus-eluting stents for Left main/three vessel disease patients
    Kang, Jeehoon
    Han, Jung-Kyu
    Kim, Chee Hae
    Kong, Min-Gyu
    Park, Jiesuck
    Yang, Han-Mo
    Park, Kyung Woo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B91 - B92
  • [30] Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial
    Head, Stuart J.
    Davierwala, Piroze M.
    Serruys, Patrick W.
    Redwood, Simon R.
    Colombo, Antonio
    Mack, Michael J.
    Morice, Marie-Claude
    Holmes, David R., Jr.
    Feldman, Ted E.
    Stahle, Elisabeth
    Underwood, Paul
    Dawkins, Keith D.
    Kappetein, A. Pieter
    Mohr, Friedrich W.
    EUROPEAN HEART JOURNAL, 2014, 35 (40) : 2821 - +